What is MedRhythms?
Founded in 2015, MedRhythms leverages the intricate connection between music and neuroscience to drive recovery for patients with neurological conditions. The company partners with leading rehabilitation hospitals across the U.S., offering comprehensive NMT services through outpatient, in-home, community, and telehealth settings. Their therapeutic interventions are designed to optimize sensorimotor, speech and language, and cognitive goals for diverse patient populations, including those recovering from traumatic brain injury, stroke, and neurodegenerative diseases. MedRhythms is dedicated to advancing clinical excellence and innovation within the NMT field, aiming to enhance the quality of life for individuals across all care levels.
How much funding has MedRhythms raised?
MedRhythms has raised a total of $5.7M across 3 funding rounds:
Series A
$5.3M
Debt
$150K
Debt
$272K
Series A (2018): $5.3M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2021): $272K supported by PPP
What's next for MedRhythms?
The recent major strategic investment signals a pivotal growth phase for MedRhythms. This capital infusion is expected to accelerate the company's expansion efforts, potentially enabling broader market penetration and further development of its NMT platform. The focus on strategic backing suggests a move towards scaling operations and solidifying its position as a leader in neurorehabilitation technology. Future initiatives may include enhancing clinical research, expanding partnerships with healthcare providers, and refining their service delivery models to reach a wider patient base.
See full MedRhythms company page
